Combination of polymeric micelle formulation of TGFβ receptor inhibitors and paclitaxel produces consistent response across different mouse models of Triple‐negative breast cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Bioengineering & Translational Medicine

Topics

Chemistry

Biochemistry

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1002/btm2.10681

License

CC-BY

Other Formats

PDF